Affordable Access

Publisher Website

IONTOPHORESIS FOR TREATMENT OF PEYRONIE’S DISEASE

Authors
Journal
The Journal of Urology
0022-5347
Publisher
Elsevier
Publication Date
Volume
163
Issue
1
Identifiers
DOI: 10.1016/s0022-5347(05)67981-5
Keywords
  • Penile Induration
  • Iontophoresis
Disciplines
  • Medicine

Abstract

Purpose: We evaluate the efficacy of iontophoresis of dexamethasone, lidocaine and verapamil to treat Peyronie’s disease. Materials and Methods: In an uncontrolled prospective study 100 unselected patients with Peyronie’s disease were treated with 3 weekly courses of iontophoresis. The drug mixture was administered by an electrical current of 5 mA. and a self-adhesive receptacle fixed to the penile skin overlying the plaque. Results: Resolution of pain was observed in 96% of patients, plaque diminution in 53% and improvement of penile deviation in 37%. Impaired sexual function was improved in 19 of 43 patients (44%). The benefit of iontophoresis therapy was more pronounced in patients with a short history of disease. Because of lack of side effects and painless administration iontophoresis was well tolerated and accepted by all patients. Conclusions: Iontophoresis of dexamethasone, lidocaine and verapamil may be regarded as first line nonsurgical treatment for Peyronie’s disease.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Iontophoresis for treatment of Peyronie's disease.

on The Journal of Urology January 2000

[Iontophoresis in the conservative treatment of Pe...

on Archivio italiano di urologia,... December 1997

[Iontophoresis in Peyronie's disease. Our experien...

on Archivos españoles de urologi... December 2003
More articles like this..